[10] SURMOUNT-1 : Tirzepatide for the treatment of obesity produced ~2022% weight loss over 72 weeks, among the largest effects seen in pharmacologic obesity treatment
Interestingly, Liraglutide 10100nM increased adiponectin ( ADIPOQ) expression [13] and in one study it led to an initial upregulation of PPAR and C/EBP followed by a significant downregulation, while preadipocyte marker Pref-1 was gradually increased [20]
Didangelos, T., Karlafti, E., Kotzakioulafi, E., Margariti, E., Giannoulaki, P., Batanis, G., Tesfaye, S., & Kantartzis, K
No preservatives, artificial colors or synthetic colors
Importantly, it works with the bodys natural pulsatile GH rhythm rather than overriding it, preserving normal regulatory dynamics